Abstract Search System
International Session (Workshop)1 (JSGE, JGES, JSGS)
Host-microbial interaction in IBD
24th, 14:40–17:00, Room 5 (Portopia Hotel South Wing Ohwada A)
Presentation Time (Presentation time varies depending on the presentation. Please prepare your presentation within the time limit time, shown as below)
· Presentation No. IS-W1-Keynote — Presentation 20 minutes
· Other Presentations except IS-W1-Keynote — Presentation: 10 minutes, Q&A: 2 minutes
Discussion: No discussion will be held.
Pre-meeting: There is no pre-meeting for this session.
· Presentation No. IS-W1-Keynote — Presentation 20 minutes
· Other Presentations except IS-W1-Keynote — Presentation: 10 minutes, Q&A: 2 minutes
Discussion: No discussion will be held.
Pre-meeting: There is no pre-meeting for this session.
-
Chairperson: A.Andoh
(Department of Medicine, Shiga University of Medical Science) -
Chairperson: H.Nakase
(Department of Gastroenterology and Hepatology, Endoscopic Medicine, Kyoto University)
IS-W1-KeynoteOral administration of dimeric monoclonal IgA antibody as a candidate therapeutic approach for spontaneous colitis in mice.
IS-W1-1A novel probiotics isolated from Japanese "Funazushi" potently exerts a therapeutic effect on DSS-induced colitis
IS-W1-2TGF-beta signaling on dendritic cells regulates bacterial communities and gut homeostasis
IS-W1-3Fecal lipocalin2; Potential candidate for a novel biomarker for monitoring colonic inflammation in inflammatory bowel disease
IS-W1-4Enzyme-modified cheese suppresses intestinal inflammation in rats
IS-W1-5Partially hydrolyzed guar gum (PHGG) inhibited the intestinal inflammation through the regulation of commensal microbiota
IS-W1-6A novel host-microbial interaction via the uptake of probiotic-derived molecules by intestinal epithelia
IS-W1-7Dysbiosis of intestinal and oral microbiota in pediatric primary sclerosing cholangitis
IS-W1-8The Relationship between Fusicatenibacter saccharivorans and Inflammatory Bowel Disease.
IS-W1-9Identification of commercial microbes contributing to dysbiosis of Japanese patients with Crohn's disease.
IS-W1-10Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: a randomized, double-blinded, placebo-controlled multicenter trial
International Session (Workshop)2 (JSGS, JSGE, JGES)
Global current status on gastric cancer treatment≪Video≫
25th, 9:45–12:00, Room 5 (Portopia Hotel South Wing Ohwada A)
Presentation Time — Presentation: 15 minutes, Q&A: 4 minutes
Discussion: No discussion will be held.
Pre-meeting: There is no pre-meeting for this session.
Discussion: No discussion will be held.
Pre-meeting: There is no pre-meeting for this session.
-
Chairperson: T.Sano
(Department of Gastroenterological Surgery, Cancer Institute Hospital) -
Chairperson: I.Oda
(Endoscopy Division, National Cancer Center Hospital)
IS-W2-1Endoscopic treatment of gastric cancer in Korea
IS-W2-2Endoscopic treatment of early gastric cancer in Japan
IS-W2-3Laparoscopic Total Gastrectomy
IS-W2-4Standard surgery for gastric cancer in UK
IS-W2-5Standard surgery for gastric cancer in Germany (Video)
IS-W2-6Surgical treatment of gastric cancer in China
IS-W2-7Surgery for locally advanced gastric cancer by open approach
International Session (Workshop)3 (JGES)
International ESD hands-on seminar
25th, 14:00–17:00, Room 7 (Portopia Hotel South Wing Ohwada C)
Presentation Time — Presentation: 5 minutes, Q&A: 2 minutes
Discussion: No discussion will be held.
Pre-meeting: October 25 (Sat.) 12:00–13:30 («Ikuta», Portopia Hotel Main Building B1F); Lunch will be provided. Prof. Yakabi will also be present in the pre-meeting.
Discussion: No discussion will be held.
Pre-meeting: October 25 (Sat.) 12:00–13:30 («Ikuta», Portopia Hotel Main Building B1F); Lunch will be provided. Prof. Yakabi will also be present in the pre-meeting.
-
Chairperson: T.Gotoda
(Department of Gastroenterology & Hepatology, Tokyo Medical University) -
Chairperson: M.Fujishiro
(Department of Endoscopy and Endoscopic Surgery, The University of Tokyo Hospital)